NNK-Induced Lung Tumors: A Review of Animal Model

The incidence of lung adenocarcinoma has been remarkably increasing in recent years due to the introduction of filter cigarettes and secondary-hand smoking because the people are more exposed to higher amounts of nitrogen oxides, especially 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone(NNK), which is widely applied in animal model of lung tumors. In NNK-induced lung tumors, genetic mutation, chromosome instability, gene methylation, and activation of oncogenes have been found so as to disrupt the expression profiles of some proteins or enzymes in various cellular signal pathways. Transgenic animal with specific alteration of lung cancer-related molecules have also been introduced to clarify the molecular mechanisms of NNK in the pathogenesis and development of lung tumors. Based on these animal models, many antioxidant ingredients and antitumor chemotherapeutic agents have been proved to suppress the NNK-induced lung carcinogenesis. In the future, it is necessary to delineate the most potent biomarkers of NNK-induced lung tumorigenesis, and to develop efficient methods to fight against NNK-associated lung cancer using animal models.

[1]  T. Veenstra,et al.  Identification of a Highly Effective Rapamycin Schedule that Markedly Reduces the Size, Multiplicity, and Phenotypic Progression of Tobacco Carcinogen–Induced Murine Lung Tumors , 2006, Clinical Cancer Research.

[2]  K. Yeum,et al.  The effects of combined antioxidant (β‐carotene, α‐tocopherol and ascorbic acid) supplementation on antioxidant capacity, DNA single‐strand breaks and levels of insulin‐like growth factor‐1/IGF‐binding protein 3 in the ferret model of lung cancer , 2007, International journal of cancer.

[3]  K. Tsuneyama,et al.  High-density oligonucleotide microarrays and functional network analysis reveal extended lung carcinogenesis pathway maps and multiple interacting genes in NNK [4-(methylnitrosamino)-1-(3-pyridyle)-1-butanone] induced CD1 mouse lung tumor , 2006, Journal of Cancer Research and Clinical Oncology.

[4]  Marshall W. Anderson,et al.  Carcinogen-specific targeting of chromosome 12 for loss of heterozygosity in mouse lung adenocarcinomas: implications for chromosome instability and tumor progression , 2004, Oncogene.

[5]  S. Amin,et al.  Comparison of the Chemopreventive Efficacies of 1,4-phenylenebis(methylene)selenocyanate and Selenium-Enriched Yeast on 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone Induced Lung Tumorigenesis in A/J Mouse , 2003, Nutrition and Cancer.

[6]  K. Saoo,et al.  Lack of modifying potential of 8-methoxypsoralen in the promotion or progression stages of lung carcinogenesis in A/J female mice. , 2008, Oncology reports.

[7]  Q. S. Wang,et al.  Expression of cell cycle proteins in 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced mouse lung tumors. , 1998, Experimental lung research.

[8]  H. Schuller,et al.  beta-Carotene promotes the development of NNK-induced small airway-derived lung adenocarcinoma. , 2009, European journal of cancer.

[9]  J. Liao,et al.  Inhibition of Lung Carcinogenesis and Effects on Angiogenesis and Apoptosis in A/J Mice by Oral Administration of Green Tea , 2004, Nutrition and cancer.

[10]  A. Mukherjee,et al.  Increased Susceptibility of Mice Lacking Clara Cell 10-kDa Protein to Lung Tumorigenesis by 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone, a Potent Carcinogen in Cigarette Smoke* , 2004, Journal of Biological Chemistry.

[11]  K. Saoo,et al.  Establishment of a bioassay model for lung cancer chemoprevention initiated with 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in female A/J mice. , 2008, Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie.

[12]  J. Becker,et al.  Nitrosamine 4‐(methylnitrosamino)‐1‐(3‐pyridyl)‐1‐butanone‐induced pulmonary adenocarcinomas in Syrian golden hamsters contain beta 2‐adrenergic receptor single‐nucleotide polymorphisms , 2005, Genes, chromosomes & cancer.

[13]  M. You,et al.  CHEMOPREVENTIVE EFFICACY OF PROMISING FARNESYLTRANSFERASE INHIBITORS , 2000, Experimental lung research.

[14]  S. Hecht,et al.  The biological significance of tobacco-specific N-nitrosamines: smoking and adenocarcinoma of the lung. , 1996, Critical reviews in toxicology.

[15]  S. Amin,et al.  Chemopreventive efficacy of suberoylanilide hydroxamic acid (SAHA) against 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)-induced lung tumorigenesis in female A/J mice. , 2003, Anticancer research.

[16]  K. Tsuneyama,et al.  Oncogenic role of JC virus in lung cancer , 2007, The Journal of pathology.

[17]  V. Steele,et al.  Prevention of mouse lung tumors by targretin , 2006, International journal of cancer.

[18]  Y. Yano,et al.  The suppression of ornithine decarboxylase expression and cell proliferation at the promotion stage of lung tumorigenesis in mice by alpha-tocopheryloxybutyric acid. , 2001, Biochemical pharmacology.

[19]  Y. Yano,et al.  The inhibitory effect of vitamin E on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis in mice based on the regulation of polyamine metabolism. , 1998, Cancer letters.

[20]  T. Yano,et al.  The inhibitory effect of vitamin E on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced DNA injury and the fixation of the DNA injury in mouse lungs , 1998, Naunyn-Schmiedeberg's Archives of Pharmacology.

[21]  Xiang‐Dong Wang,et al.  Fish Oil Supplementation Inhibits NNK-Induced Lung Carcinogenesis in the A/J Mouse , 2009, Nutrition and Cancer.

[22]  H. Tomita,et al.  Chemopreventive effects of fermented brown rice and rice bran against 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis in female A/J mice. , 2009, Oncology reports.

[23]  F. Chung.  CHEMOPREVENTION OF LUNG CANCER BY ISOTHIOCYANATES AND THEIR CONJUGATES IN A/J MOUSE , 2001, Experimental lung research.

[24]  A. Malkinson,et al.  The Role of CC10 in Pulmonary Carcinogenesis: From a Marker to Tumor Suppression , 2000, Annals of the New York Academy of Sciences.

[25]  F. Jirik,et al.  Mgmt deficiency alters the in vivo mutational spectrum of tissues exposed to the tobacco carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK). , 2008, Carcinogenesis.

[26]  B. Lai,et al.  Induction of lung lesions in Wistar rats by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and its inhibition by aspirin and phenethyl isothiocyanate , 2007, BMC Cancer.

[27]  R. Lotan,et al.  Comparative Functional Genomics Analysis of NNK Tobacco-Carcinogen Induced Lung Adenocarcinoma Development in Gprc5a-Knockout Mice , 2010, PloS one.

[28]  J. Siegfried,et al.  Transgenic mice overexpressing hepatocyte growth factor in the airways show increased susceptibility to lung cancer. , 2005, Carcinogenesis.

[29]  A. Nishikawa,et al.  Effects of protocatechuic acid, S-methylmethanethiosulfonate or 5-hydroxy-4-(2-phenyl-(E)ethenyl)-2(5H)-furanone(KYN-54) on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced pulmonary carcinogenesis in mice. , 1999, Cancer letters.

[30]  K. Tsuneyama,et al.  Targeted disruption of the galectin-3 gene results in decreased susceptibility to NNK-induced lung tumorigenesis: an oligonucleotide microarray study , 2008, Journal of Cancer Research and Clinical Oncology.

[31]  M. You,et al.  Inhibition of COX-2 and induction of apoptosis: two determinants of nonsteroidal anti-inflammatory drugs' chemopreventive efficacies in mouse lung tumorigenesis. , 2000, Experimental lung research.

[32]  Takuji Tanaka,et al.  Inhibitory effect of mandarin juice rich in β-cryptoxanthin and hesperidin on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced pulmonary tumorigenesis in mice , 2001 .

[33]  H. Maeta,et al.  Pretreatment with 8-methoxypsoralen, a potent human CYP2A6 inhibitor, strongly inhibits lung tumorigenesis induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in female A/J mice. , 2003, Cancer research.

[34]  R. Russell,et al.  Combined antioxidant (β-carotene, α-tocopherol and ascorbic acid) supplementation increases the levels of lung retinoic acid and inhibits the activation of mitogen-activated protein kinase in the ferret lung cancer model , 2006 .

[35]  S. Shin,et al.  High oleic acid oil suppresses lung tumorigenesis in mice through the modulation of extracellular signal-regulated kinase cascade , 2002, Lipids.

[36]  T. Massey,et al.  Investigation of the role of lipoxygenase in bioactivation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in human lung. , 2002, Chemical research in toxicology.

[37]  G. Kim,et al.  Inhibitory effects of 7-hydroxy-3-methoxy-cadalene on 4-(methylinitrosamino)-1-(3-pyridyl)-1-butanone (NNK)-induced lung tumorigenesis in A/J mice. , 2004, Cancer letters.

[38]  S. Amin,et al.  Evaluation of the transplacental tumorigenicity of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in mice. , 1989, Cancer research.

[39]  F. Chung.  The prevention of lung cancer induced by a tobacco-specific carcinogen in rodents by green and black Tea. , 1999, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[40]  M. Tamura,et al.  Angiotensin II type 2 receptor gene deficiency attenuates susceptibility to tobacco-specific nitrosamine-induced lung tumorigenesis: involvement of transforming growth factor-beta-dependent cell growth attenuation. , 2005, Cancer research.

[41]  K. Kiyotani,et al.  Genetic polymorphism of CYP2A6 as one of the potential determinants of tobacco-related cancer risk. , 2005, Biochemical and biophysical research communications.

[42]  Jie Liao,et al.  Inhibition of adenoma progression to adenocarcinoma in a 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis model in A/J mice by tea polyphenols and caffeine. , 2006, Cancer research.

[43]  V. Steele,et al.  K-ras mutations in lung tumors from A/J and A/J x TSG-p53 F1 mice treated with 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and phenethyl isothiocyanate. , 1995, Carcinogenesis.

[44]  A. Zhu,et al.  9-cis-Retinoic acid inhibition of lung carcinogenesis in the A/J mouse model is accompanied by increased expression of RAR-beta but no change in cyclooxygenase-2. , 2006, Cancer letters.

[45]  L. Kaminsky,et al.  Determination of the role of target tissue metabolism in lung carcinogenesis using conditional cytochrome P450 reductase-null mice. , 2007, Cancer research.

[46]  S. Hecht,et al.  Indole-3-carbinol inhibits 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone plus benzo(a)pyrene-induced lung tumorigenesis in A/J mice and modulates carcinogen-induced alterations in protein levels. , 2007, Cancer research.

[47]  Toshiaki Okada,et al.  Point mutation of K-ras gene in cisplatin-induced lung tumours in A/J mice. , 2007, Lung cancer.

[48]  R. Price,et al.  Chemopreventive effects of deguelin, a novel Akt inhibitor, on tobacco-induced lung tumorigenesis. , 2005, Journal of the National Cancer Institute.

[49]  E. Fiala,et al.  Chemoprevention of lung tumorigenesis induced by a mixture of benzo(a)pyrene and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by the organoselenium compound 1,4-phenylenebis(methylene)selenocyanate. , 2000, Cancer letters.

[50]  S. Amin,et al.  Array CGH analysis reveals chromosomal aberrations in mouse lung adenocarcinomas induced by the human lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. , 2006, Biochemical and biophysical research communications.

[51]  H. Plummer,et al.  The tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone is a beta-adrenergic agonist and stimulates DNA synthesis in lung adenocarcinoma via beta-adrenergic receptor-mediated release of arachidonic acid. , 1999, Cancer research.

[52]  S. Amin,et al.  The organoselenium compound 1,4-phenylenebis(methylene)selenocyanate inhibits 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced tumorgenesis and enhances glutathione-related antioxidant levels in A/J mouse lung. , 2006, Chemico-biological interactions.

[53]  J H Weisburger,et al.  Mechanisms of chronic disease causation by nutritional factors and tobacco products and their prevention by tea polyphenols. , 2002, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[54]  J. Mulshine,et al.  Inhaled isotretinoin (13-cis retinoic acid) is an effective lung cancer chemopreventive agent in A/J mice at low doses: a pilot study. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[55]  W. Hung,et al.  Antiproliferative and chemopreventive effects of adlay seed on lung cancer in vitro and in vivo. , 2003, Journal of agricultural and food chemistry.

[56]  K. Mitsumori,et al.  Inhibitory effects of cinnamaldehyde on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung carcinogenesis in rasH2 mice. , 2002, Cancer letters.

[57]  T. Hanson,et al.  Chemopreventive Effect of Kava on 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone plus Benzo[a]pyrene–Induced Lung Tumorigenesis in A/J Mice , 2007, Cancer Prevention Research.

[58]  S. Belinsky,et al.  Role of the alveolar type II cell in the development and progression of pulmonary tumors induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in the A/J mouse. , 1992, Cancer research.

[59]  J. Petrik,et al.  The function of IGF-IR in NNK-mediated lung tumorigenesis. , 2011, Lung cancer.

[60]  Lili Liu,et al.  Reduced lung tumorigenesis in human methylguanine DNA--methyltransferase transgenic mice achieved by expression of transgene within the target cell. , 1999, Carcinogenesis.

[61]  S. Belinsky,et al.  Aberrant Promoter Hypermethylation of the Death-Associated Protein Kinase Gene Is Early and Frequent in Murine Lung Tumors Induced by Cigarette Smoke and Tobacco Carcinogens , 2004, Cancer Research.

[62]  Yan Zeng,et al.  Differential expression of microRNAs in early-stage neoplastic transformation in the lungs of F344 rats chronically treated with the tobacco carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. , 2008, Carcinogenesis.

[63]  S. Hecht,et al.  Eukaryotic initiation factor 4E binding protein family of proteins: sentinels at a translational control checkpoint in lung tumor defense. , 2009, Cancer research.

[64]  J. Szakacs,et al.  Chemopreventive activity of selenocysteine prodrugs against tobacco‐derived nitrosamine (NNK) induced lung tumors in the A/J mouse , 2006, Journal of biochemical and molecular toxicology.

[65]  K. Kiura,et al.  Effect of gefitinib on N-nitrosamine-4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone induced lung tumorigenesis in A/J mice. , 2009, Lung cancer.

[66]  S. Hecht,et al.  Phenethyl isothiocyanate and sulforaphane and their N-acetylcysteine conjugates inhibit malignant progression of lung adenomas induced by tobacco carcinogens in A/J mice. , 2005, Cancer research.

[67]  P. Dennis,et al.  Strain-specific spontaneous and NNK-mediated tumorigenesis in Pten+/- mice. , 2008, Neoplasia.

[68]  R. Russell,et al.  Inhibition of lung carcinogenesis by 1α,25‐dihydroxyvitamin D3 and 9‐cis retinoic acid in the A/J mouse model: Evidence of retinoid mitigation of vitamin D toxicity , 2007, International journal of cancer.

[69]  A. Ehrhardt,et al.  Increased susceptibility to the tobacco carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in transgenic mice overexpressing c-myc and epidermal growth factor in alveolar type II cells , 2003, Journal of Cancer Research and Clinical Oncology.

[70]  Gary T. Smith,et al.  Detection of Overexpressed COX‐2 in Precancerous Lesions of Hamster Pancreas and Lungs by Molecular Imaging: Implications for Early Diagnosis and Prevention , 2006, ChemMedChem.

[71]  Arunangshu Das,et al.  Down-regulation of 14-3-3 isoforms and annexin A5 proteins in lung adenocarcinoma induced by the tobacco-specific nitrosamine NNK in the A/J mouse revealed by proteomic analysis. , 2009, Journal of Proteome Research.

[72]  H. Witschi,et al.  The Effects of Dietary Myoinositol on Lung Tumor Development in Tobacco Smoke-Exposed Mice , 2004, Inhalation toxicology.

[73]  H. Jeong,et al.  Chemopreventive effect of saponins derived from roots ofPlatycodon grandiflorum on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis in A/J mice , 2006, Archives of pharmacal research.

[74]  S. Belinsky,et al.  Carcinogen exposure differentially modulates RAR-beta promoter hypermethylation, an early and frequent event in mouse lung carcinogenesis. , 2003, Carcinogenesis.

[75]  M. You,et al.  USE OF p53 TRANSGENIC MICE IN THE DEVELOPMENT OF CANCER MODELS FOR MULTIPLE PURPOSES , 2000, Experimental lung research.

[76]  Anthony J Alberg,et al.  Epidemiology of lung cancer: looking to the future. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[77]  S. Sugano,et al.  Enhancement of lung carcinogenesis initiated with 4-(N-hydroxymethylnitrosamino)-1-(3-pyridyl)-1-butanone by Ogg1 gene deficiency in female, but not male, mice. , 2009, The Journal of toxicological sciences.